Renol Polychem Limited (NSE:RNPL)
64.30
-1.70 (-2.58%)
At close: Oct 23, 2026
Renol Polychem Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 111.37 | 29.67 | 10.14 | 1.21 | 0.65 |
Cash & Short-Term Investments | 111.37 | 29.67 | 10.14 | 1.21 | 0.65 |
Cash Growth | 275.39% | 192.67% | 739.16% | 86.13% | - |
Accounts Receivable | 653.61 | 89.67 | 62.02 | 47.92 | 30.13 |
Other Receivables | 0.13 | 0.03 | - | - | - |
Receivables | 654.58 | 90.03 | 62.02 | 51.95 | 35.46 |
Inventory | 507.15 | 92.68 | 69.22 | 31.05 | 12.02 |
Prepaid Expenses | 0.53 | - | - | - | - |
Other Current Assets | 123.05 | 11.54 | 7.52 | 6.04 | 7.95 |
Total Current Assets | 1,397 | 223.92 | 148.89 | 90.25 | 56.08 |
Property, Plant & Equipment | 221.64 | 3.42 | 3.86 | 2.16 | 2.38 |
Long-Term Investments | 74.44 | 3.01 | - | - | 0.23 |
Goodwill | 123.5 | - | - | - | - |
Other Intangible Assets | 0.35 | - | - | - | - |
Long-Term Accounts Receivable | 104.44 | 2.45 | 1.21 | 10.22 | - |
Long-Term Deferred Tax Assets | 39.38 | 0.54 | 0.44 | 0.13 | 0.11 |
Other Long-Term Assets | 2.62 | 0.73 | 0.53 | - | 8.08 |
Total Assets | 2,007 | 234.08 | 154.93 | 102.75 | 66.87 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 575.07 | 11.1 | 22.59 | 17.73 | 5.68 |
Accrued Expenses | 9.61 | 0.72 | 0.57 | 0.06 | 0.12 |
Short-Term Debt | 124.71 | 66.92 | 21.96 | 37.27 | - |
Current Portion of Long-Term Debt | 12.06 | 1.32 | 1.21 | - | - |
Current Income Taxes Payable | 28.79 | 16.77 | 16.57 | 2.55 | 0.54 |
Other Current Liabilities | 16.2 | 2.62 | 2.48 | 1.79 | 3.69 |
Total Current Liabilities | 766.44 | 99.45 | 65.38 | 59.39 | 10.02 |
Long-Term Debt | 34.16 | 1.31 | 2.63 | 16.3 | 38.04 |
Other Long-Term Liabilities | 0.11 | 0 | - | - | - |
Total Liabilities | 800.71 | 100.76 | 68 | 75.69 | 48.06 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 120.85 | 54.9 | 54.9 | 27.06 | 18.81 |
Additional Paid-In Capital | 716.28 | 0.1 | 0.1 | - | - |
Retained Earnings | 160.31 | 78.32 | 31.93 | - | - |
Comprehensive Income & Other | 86.49 | - | - | - | - |
Total Common Equity | 1,084 | 133.32 | 86.93 | 27.06 | 18.81 |
Minority Interest | 122.52 | - | - | - | - |
Shareholders' Equity | 1,206 | 133.32 | 86.93 | 27.06 | 18.81 |
Total Liabilities & Equity | 2,007 | 234.08 | 154.93 | 102.75 | 66.87 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 170.92 | 69.55 | 25.79 | 53.57 | 38.04 |
Net Cash (Debt) | -59.55 | -39.88 | -15.65 | -52.36 | -37.39 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -4.86 | -7.26 | -2.85 | -7.19 | - |
Filing Date Shares Outstanding | 12.08 | 5.49 | 5.49 | 7.28 | - |
Total Common Shares Outstanding | 12.08 | 5.49 | 5.49 | 7.28 | - |
Working Capital | 630.24 | 124.47 | 83.52 | 30.86 | 46.05 |
Book Value Per Share | 89.70 | 24.28 | 15.83 | 3.72 | - |
Tangible Book Value | 960.07 | 133.32 | 86.93 | 27.06 | 18.81 |
Tangible Book Value Per Share | 79.45 | 24.28 | 15.83 | 3.72 | - |
Land | 131.74 | - | - | 1.59 | 1.59 |
Buildings | 21.17 | - | - | - | - |
Machinery | 78.55 | 7.87 | 6.74 | 1.72 | 1.66 |